اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
ACTOS از شرکت TAKEDA PHARMS USA
New Drug Application (NDA): 021073
Company: TAKEDA PHARMS USA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/15/1999 | ORIG-1 | Approval |
Type 1 – New Molecular Entity |
PRIORITY |
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21073lbl.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/21/2017 | SUPPL-49 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021073Orig1s049ltr.pdf |
||
| 12/12/2016 | SUPPL-48 | Efficacy-Labeling Change With Clinical Data |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021073s048lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021073Orig1s048ltr.pdf |
||
| 06/27/2013 | SUPPL-47 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 11/12/2013 | SUPPL-46 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021073s046lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021073Orig1s046ltr.pdf |
||
| 05/17/2012 | SUPPL-45 | REMS-Assessment |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021073s045,021842s016,022024s009,021925s012ltr.pdf |
|
| 08/04/2011 | SUPPL-44 | Labeling-Medication Guide, Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021073Orig1s043s044-021842Orig1s014s015-022024Orig1s008s007-021925Orig1s010s011ltr.pdf |
||
| 08/04/2011 | SUPPL-43 | REMS-Modified |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021073Orig1s043s044-021842Orig1s014s015-022024Orig1s008s007-021925Orig1s010s011ltr.pdf |
||
| 07/29/2010 | SUPPL-40 | Labeling-Container/Carton Labels |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021073s040ltr.pdf |
|
| 09/09/2009 | SUPPL-37 | Labeling, REMS-Proposal |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021073s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021073s037ltr.pdf |
||
| 02/03/2011 | SUPPL-35 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf |
||
| 12/11/2008 | SUPPL-34 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021073s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021073s034ltr.pdf |
||
| 05/07/2008 | SUPPL-33 | Labeling |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021073s033ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021073s033PI.pdf |
|
| 08/14/2007 | SUPPL-31 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021073s031LTR.pdf |
||
| 09/06/2007 | SUPPL-30 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021073s030_ltr.pdf |
||
| 09/28/2006 | SUPPL-29 | Labeling |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021073s029, 021842s003LTR.pdf |
|
| 11/04/2006 | SUPPL-28 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021073s028,021842s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021073S028, 021842S002ltr.pdf |
||
| 08/30/2006 | SUPPL-27 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021073s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021073s027ltr.pdf |
||
| 02/25/2007 | SUPPL-26 | Efficacy-Labeling Change With Clinical Data |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021073s026ltr.pdf |
||
| 07/20/2004 | SUPPL-24 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21073s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21073s024ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021073_s024_ACTOS TABS.pdf |
||
| 08/03/2004 | SUPPL-23 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21073s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21073s023ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021073_s023_ACTOS TABS.pdf |
||
| 06/11/2003 | SUPPL-21 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21073slr071_actos_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21073slr071ltr.pdf |
||
| 11/26/2003 | SUPPL-20 | Efficacy-Labeling Change With Clinical Data |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21073se8-020_actos_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21073se8-020ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021073_S020_ACTOS TABLETS_AP.pdf |
||
| 12/03/2002 | SUPPL-18 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21073scp018ltr.pdf |
|
| 01/17/2003 | SUPPL-17 | Efficacy-Labeling Change With Clinical Data |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21073se8-017ltr.pdf |
|
| 01/07/2002 | SUPPL-16 | Labeling |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21073s16ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021073_S016_ACTOS.pdf |
|
| 02/28/2002 | SUPPL-15 | Manufacturing (CMC)-Control |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021073_S015_ACTOS_TABLETS.pdf |
|
| 08/03/2001 | SUPPL-14 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021073_S014_ACTOS.pdf |
|
| 10/01/2002 | SUPPL-13 | Manufacturing (CMC)-Control |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021073_S013_ACTOS_TABLETS.pdf |
|
| 05/22/2001 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021073_S012_ACTOS TABLETS.pdf |
|
| 07/02/2001 | SUPPL-11 | Labeling |
Label is not available on this site. |
||
| 07/12/2002 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21073s10lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21073se8010ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021073_S010_Actos Tablets_APPROVAL PACKAGE.pdf |
||
| 07/06/2001 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 07/06/2001 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021073_S008_ACTOS TABLETS.pdf |
|
| 04/25/2001 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021073_S007_ACTOS.pdf |
|
| 11/03/2000 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S006_ACTOS.pdf |
|
| 07/26/2000 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S005_ACTOS.pdf |
|
| 10/25/2000 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S004_ACTOS.pdf |
|
| 04/11/2000 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S003_ACTOS.pdf |
|
| 02/25/2000 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S002_ACTOS.pdf |
|
| 02/25/2000 | SUPPL-1 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021073_S001_ACTOS.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 12/21/2017 | SUPPL-49 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf | |
| 12/12/2016 | SUPPL-48 |
Efficacy-Labeling Change With Clinical Data |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021073s048lbl.pdf | |
| 11/12/2013 | SUPPL-46 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021073s046lbl.pdf | |
| 08/04/2011 | SUPPL-44 |
Labeling-Medication Guide |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf | |
| 08/04/2011 | SUPPL-44 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf | |
| 08/04/2011 | SUPPL-43 |
REMS-Modified |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf | |
| 02/03/2011 | SUPPL-35 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf | |
| 09/09/2009 | SUPPL-37 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021073s037lbl.pdf | |
| 09/09/2009 | SUPPL-37 |
REMS-Proposal |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021073s037lbl.pdf | |
| 12/11/2008 | SUPPL-34 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021073s034lbl.pdf | |
| 09/06/2007 | SUPPL-30 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s030lbl.pdf | |
| 08/14/2007 | SUPPL-31 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s031lbl.pdf | |
| 02/25/2007 | SUPPL-26 |
Efficacy-Labeling Change With Clinical Data |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021073s026lbl.pdf | |
| 11/04/2006 | SUPPL-28 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021073s028,021842s002lbl.pdf | |
| 08/30/2006 | SUPPL-27 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021073s027lbl.pdf | |
| 08/03/2004 | SUPPL-23 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21073s023lbl.pdf | |
| 07/20/2004 | SUPPL-24 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21073s024lbl.pdf | |
| 11/26/2003 | SUPPL-20 |
Efficacy-Labeling Change With Clinical Data |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21073se8-020_actos_lbl.pdf | |
| 06/11/2003 | SUPPL-21 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21073slr071_actos_lbl.pdf | |
| 07/12/2002 | SUPPL-10 |
Efficacy-Labeling Change With Clinical Data |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21073s10lbl.pdf | |
| 07/15/1999 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21073lbl.pdf |
ACTOS
TABLET;ORAL; EQ 15MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021073 | TAKEDA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 200044 | ACCORD HLTHCARE |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 204133 | ANNORA PHARMA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 200268 | AUROBINDO PHARMA LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 076798 | CELLTRION |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 202467 | MACLEODS PHARMS LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 207806 | PRINSTON INC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 206738 | PURACAP PHARM LLC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 078670 | SANDOZ |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 210165 | SHUANGCHENG |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 077210 | TEVA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL | Prescription | No | AB | 202456 | ZYDUS PHARMS USA INC |
TABLET;ORAL; EQ 30MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021073 | TAKEDA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 200044 | ACCORD HLTHCARE |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 204133 | ANNORA PHARMA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 200268 | AUROBINDO PHARMA LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 076798 | CELLTRION |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 202467 | MACLEODS PHARMS LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 207806 | PRINSTON INC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 206738 | PURACAP PHARM LLC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 078670 | SANDOZ |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 210165 | SHUANGCHENG |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 077210 | TEVA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL | Prescription | No | AB | 202456 | ZYDUS PHARMS USA INC |
TABLET;ORAL; EQ 45MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ACTOS | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021073 | TAKEDA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 200044 | ACCORD HLTHCARE |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 204133 | ANNORA PHARMA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 200268 | AUROBINDO PHARMA LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 076798 | CELLTRION |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 202467 | MACLEODS PHARMS LTD |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 207806 | PRINSTON INC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 206738 | PURACAP PHARM LLC |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 078670 | SANDOZ |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 210165 | SHUANGCHENG |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 077210 | TEVA PHARMS USA |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL | Prescription | No | AB | 202456 | ZYDUS PHARMS USA INC |
نظرات کاربران